Mechanisms of targeted therapy resistance in a pediatric glioma driven by ETV6-NTRK3 fusion
{{output}}
Chromosomal rearrangements of the NTRK genes generate kinase fusions that are targetable oncogenic drivers in diverse adult and pediatric malignancies. Despite robust clinical response to targeted NTRK inhibition, the emergence of therapeutic resistance poses ... ...
